- Home
- SABS vs WHF Comparison
SABS vs WHF Comparison
Compare SABS & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SABS | WHF |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.4M | 162.2M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | SABS | WHF |
|---|---|---|
| Price | $3.99 | $7.41 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 2 |
| Target Price | ★ $9.00 | $7.75 |
| AVG Volume (30 Days) | ★ 253.6K | 180.4K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 23.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $114,698.00 | ★ $76,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $6.39 |
| 52 Week High | $6.60 | $11.31 |
Technical Indicators
Market Signals| Indicator | SABS | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 50.58 |
| Support Level | $3.54 | $7.16 |
| Resistance Level | $4.08 | $7.84 |
| Average True Range (ATR) | 0.30 | 0.18 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 75.28 | 40.79 |
Price Performance
Historical ComparisonAbout SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.